July 13, 2016
Vaccine industries have their sights set on a new market that they hope will someday be as massive as that created by the just-shy-of-obligatory childhood vaccine schedule: pregnant women.
The industry is working with the FDA to create new rules to test and develop vaccines designed to be given to pregnant women, in order to pass antibodies on to their unborn infants. The fact that this protection would only be short-term is not viewed as a problem.
Indeed, the industry is elated at the possibility to start vaccinating – via their mothers – babies too young to receive traditional vaccines.
Industry senses new opportunity
The concept of maternal vaccination targeting the infant immune system is not a new one. As far back as the 1960s, researchers were working on such a vaccine against respiratory syncytial virus (RSV) – a common and…
View original post 541 more words